Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F11 | P03951 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | ANTXR2 | P58335 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
| ▸ | HMGCR | P04035 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28012040 | 1.00 | F11 (0.46) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL6234811 | 1.00 | F11 (0.46) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL14075098 | 1.00 | F11 (0.46) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL6553392 | 1.00 | F11 (0.46) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL10618469 | 1.00 | F11 (0.46) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL12740045 | 1.00 | F11 (0.46) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL1610093 | 1.00 | F11 (0.46) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL17327089 | 0.98 | F11 (0.44) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL19667954 | 0.91 | CYP2D6 (0.44) | F11CYP2D6THRBHSD17B10ELANE | |
| SCHEMBL16327913 | 0.88 | F11 (0.37) | F11CYP2D6THRBHSD17B10ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | F11 1973/4885CYP2D6 4391/4885THRB 2394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.